Results 21 to 30 of about 121,877 (300)
Simultaneous occurrence of prostatic adenocarcinoma and renal cell carcinoma is well documented in the literature. However, metastatic prostatic adenocarcinoma in a kidney harboring a renal cell carcinoma (RCC) is quite rare.
Monika Vyas +2 more
doaj +1 more source
Reported prostate cancer incidence rates vary greatly among cystoprostatectomy samples. We investigated how the thoroughness of prostate sampling influences prostatic carcinoma incidence in bladder cancer patients.
Jernej Mlakar, Metka Volavšek
doaj +1 more source
A Review Leveraging a Rare and Unusual Case of Basal Cell Carcinoma of the Prostate
Basal cell carcinoma (BCC) is a rare nonacinar variant of prostatic carcinoma. In spite of prostatic acinar adenocarcinoma being one of the most common carcinomas in prostate,
Lin He +3 more
doaj +1 more source
Small cell carcinoma of prostate is a neuroendocrine tumor of prostate seen in 0.5%–2% of men with carcinoma prostate. Prostate-specific antigen (PSA) is a common tumor marker which is often raised in prostatic carcinoma. However, prostatic carcinoma can
Sanjay Mhalasakant Khaladkar +3 more
doaj +1 more source
Squamous cell carcinoma of the prostate is rare and represents 0.5% to 1% of prostatic carcinomas. Transformation of prostatic adenocarcinoma into squamous cell carcinoma after LH-RH agonist intake has been reported in only 8 cases in the literature.
Hamza Ichaoui +12 more
doaj +1 more source
Study on Correlation between Serum Prostate Specific Antigen and Various Prostatic Pathology
Introduction: Prostatic enlargement that may due to any cause may give rise to bladder outlet obstruction. Prostatic specific antigen is the enzyme that is responsible for liquefaction of semen within a few minutes after it has clotted.
Nirajan Mainali +3 more
doaj +1 more source
Pseudopapillary prostatic adenocarcinoma: A diagnostic pitfall for pathologists
Prostatic adenocarcinoma and urothelial carcinoma are common tumours seen in elderly patients. They both act as a close differential diagnosis for each other clinically as well as histologically.
Anuj Verma +3 more
doaj +1 more source
KI-67 IMMUNOHISTOHEMICAL EXPRESSION IN PROSTATIC LESIONS
Background: The cell proliferation marker, ki-67, is a nuclear and nucleolar protein, which can be detected during all active phases of the cell cycle (G1, S, G2, and mitosis), but absent from cell resting phases.
Inas A. Rasheed +2 more
doaj +6 more sources
Evaluation of Relationship between CD38 Expression and Gleason Score in Prostatic Carcinoma [PDF]
Background and purpose: Prostate cancer is the most prevalent non-cutaneous malignancy in men. The Gleason grading system is an important prognostic factor in prostatic carcinoma.
Mohsen Besharati Rad +1 more
doaj
Histopathological study of Prostatic Lesions in a Tertiary Care Hospital, Lahore [PDF]
Objective: To determine the spectrum of pathological lesions seen in prostatic biopsies & to grade prostatic cancers according to the modified Gleason score & grade.
Madiha Arshad +2 more
doaj

